}

Memphis Pharmaceutical’s profits decline 4%YoY in FY 2025/26

Updated 7/30/2026 10:30:00 AM
Memphis Pharmaceutical’s profits decline 4%YoY in FY 2025/26

Arab Finance: Memphis Pharmaceutical and Chemical Industries reported a 4% year-on-year plunge in net profits after tax in the fiscal year (FY) 2025/2026, according to the firm’s financial indicators.

The company recorded EGP 483.868 million in net profits after tax last FY, down from EGP 505.280 million during FY 2024/2025.

Meanwhile, revenues grew 13% to EGP 1.705 billion from EGP 1.507 billion.

Memphis is one of the oldest pharmaceutical and chemical companies in the Middle East and has been in the market since 1940.

Related News